… beta-adrenergic and anticholinergic bronchodilators (1). In the … MDIs for delivering
bronchodilators in mechanically ventilated … basis for inhaled bronchodilator therapy in these …

… combined inhaled bronchodilator therapy slightly increased theiroverall use of inhaled
bronchodilators. However, the higher consumptionof inhaled bronchodilators observed among …

… three inhalation regimens in which a β 2 -agonist (terbutaline, 2000 μg daily) was combined
with a corticosteroid (beclomethasone, 800 μg daily), an anticholinergic bronchodilator (…

… many potential benefits for combination bronchodilator therapy in patients with COPD. …
benefits of combination inhaled bronchodilator therapy. Key Words: bronchodilators, COPD, …

… and formoterol first became available for maintenance therapy of COPD more than 15
years … maintenance monotherapy bronchodilator in COPD [11]. Inhaled bronchodilators, as …

… inhaled albuterol across the three repetitions did not relate closely to symptomatic response
to either albuterol or … tests to subjects who showed small response to inhaled bronchodilator, …

Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

… We conclude that long-term therapy with inhaled albuterol improves lung function in CF
patients, but only in those with bronchial hyperresponsiveness as demonstrated by …

… disease course during bronchodilator therapy alone (an annual … also treated with an inhaled
corticosteroid (beclomethasone … of their disease during bronchodilator therapy alone was …

… risk-benefit of inhaled triple therapy, consisting of inhaled corticosteroid, long-… bronchodilation
for chronic obstructive pulmonary disease (COPD). We aimed to compare a single-inhaler …